Search

everythinglearnresearchcommunity

for

Search:↓

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

Modified laparoscopic sleeve gastrectomy effectively controls diabetes and treats obesity with minimal complications.

Women with PCOS have more depression and stress due to high androgen levels, not obesity or insulin resistance.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Women with PCOS may have higher bad cholesterol and are at risk for blood sugar issues; lifestyle changes are recommended.

Inositol was more effective than Metformin in treating symptoms of PCOS in women.

Higher myostatin and insulin resistance are linked to androgenetic alopecia.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

People with alopecia areata have higher insulin resistance.

The supplement with Myo-inositol and D-chiro-inositol improves metabolic symptoms in PCOS, especially when combined with metformin.

People with androgenic alopecia are more likely to have metabolic syndrome than healthy individuals.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

People with hair loss have higher risk of high blood sugar and diabetes, and lower levels of a specific hormone.

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Brazilian women with PCOS and both menstrual irregularity and high male hormone levels have a higher chance of having metabolic syndrome.

Insulin resistance is not more common in idiopathic hirsutism patients than in healthy individuals.

High Nesfatin-1 and low Vitamin D may increase blood pressure and heart rate in women with PCOS.

Hair loss linked to higher heart disease risk in both men and women.

Patients with acanthosis nigricans often have insulin resistance and signs of increased male hormones, but treatment targeting these male hormones is generally ineffective.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Low vitamin D levels may affect ovulation and progesterone in infertile women.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

Most women with PCOS have insulin resistance, especially those with phenotype B.